"The global pharmaceutical market grew to US$712 billion in 2007 at a compound annual growth rate (CAGR) of 10.0% between 1999 and 2007. Year-on-year the global pharmaceutical market increased to 10.7% in 2007, largely as a result of strong sales for new innovative products and high market growth in emerging pharmaceutical markets such as China."
2008 updated version of this best-selling report!
Pharmaceutical Market Trends, 2008 - 2012: Key market forecasts & growth opportunities presents a detailed trend analysis of the global pharmaceutical market to the end of 2007 and forecasts until 2012. The 142 page report presents a series of market forecasts and growth opportunities in order to help inform pharmaceutical decision-making, particularly in the areas of corporate planning, portfolio management and market forecasting.
The data and analysis contained within the report are comprehensive, consistent and up-to-date in order to provide a single-point reference for understanding key pharmaceutical market trends in 2008.
HEADLINE FINDINGS INCLUDE
- The global pharmaceutical market is forecast to grow to $929 billion in 2012, an equivalent compound annual growth rate (CAGR) of 5.5% over the next five years.
- In 2007 the leading therapy areas by sales were CNS with 16.5% share and cardiovascular with 15.4%.
- Four of the top 10 products in 2007 are forecast to increase sales over the next five years.
- The US retail pharmaceutical market grew to $206 billion but growth rates fell due to loss of patent protection on some blockbusters
- France, Germany and the UK together accounted for almost 50% of all European pharmaceutical sales in 2007.
- The top 100 blockbuster drugs generated sales of $252.5 billion, accounting for 35.5% of the total pharmaceutical market.
- The leading blockbuster by increased sales revenues in 2007 was the blood agent product Plavix (clopidogrel bisulfate), marketed by Sanofi-Aventis and Bristol-Myers Squibb.
- There were a total of 61 companies generating pharmaceutical sales in excess of $1 billion in 2007
KEY FEATURES OF THE REPORT
- Comprehensive market trends for key countries, regions, therapy areas, products and companies.
- Country profiles for leading pharma markets with market segment trends and five year forecasts.
- Therapy area profiles for leading therapeutic classes and key products and 2010 sales forecasts.
- Detailed profiles of 10 leading pharmaceutical products in 2007, including five year future sales forecasts.
- Detailed profiles of 10 leading pharmaceutical companies in 2007, including 2012 sales forecasts.(AstraZeneca, Eli Lilly, GlaxoSmithKline, Johnson and Johnson, Merck & Co, Novartis, Pfizer, Roche, Sanofi-Aventis Wyeth)
Other selected research from the 'Markets' category:
Pharmaceuticals in Japan
Pharmaceuticals in Japan industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry. Learn More
Partneringreview 2006 Vol 4 Ch 3: Late stage: registration, approval and marketed (PR06V4C03)